Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diaddin Hamdan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Genes & Diseases|January 26, 2024
The germline genetics of mild-to-moderate penetrance: An intriguing role of <i>PRAME</i> in multiple carcinogenesisDiaddin Hamdan, Van Tai Nguyen, Justine Paris, et al.
Oncotarget|May 15, 2020
Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancerTu Dao, Guillaume Gapihan, Christophe Leboeuf, et al.
International Journal of Molecular Sciences|December 16, 2018
Targeting Cancer Stem Cells to Overcome ChemoresistanceToni Nunes, Diaddin Hamdan, Christophe Leboeuf, et al.
Oncotarget|May 24, 2015
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinomaGuilhem Bousquet, Morad El Bouchtaoui, Christophe Leboeuf, et al.
Experimental Hematology & Oncology|April 19, 2025
Anti-angiogenic tyrosine kinase inhibitors and the pathophysiology of their toxic effects: revisiting the treatment of anemia in metastatic cancersTai Van Nguyen, Eurydice Angeli, Diaddin Hamdan, et al.
Nano Letters|August 29, 2025
Photodynamic Therapy Using Pulsed-Laser Irradiation of Gold Nanoparticles for the Treatment of Cancers with High Basal Oxidative StressLéa Tourneur, Syrine Gueffrache, Khanh-van Do, et al.
Experimental Hematology & Oncology|April 15, 2024
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastasesEurydice Angeli, Justine Paris, Olivier Le Tilly, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 30, 2026
Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experienceJelena Filipovic, Emma Anjorand, Laetitia Marisa, et al.
Clinical and Translational Medicine|March 22, 2024
PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancersJustine Paris, Claire Wilhelm, Celeste Lebbé, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Genes & Diseases|January 26, 2024
The germline genetics of mild-to-moderate penetrance: An intriguing role of <i>PRAME</i> in multiple carcinogenesisDiaddin Hamdan, Van Tai Nguyen, Justine Paris, et al.
Oncotarget|May 15, 2020
Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancerTu Dao, Guillaume Gapihan, Christophe Leboeuf, et al.
International Journal of Molecular Sciences|December 16, 2018
Targeting Cancer Stem Cells to Overcome ChemoresistanceToni Nunes, Diaddin Hamdan, Christophe Leboeuf, et al.
Oncotarget|May 24, 2015
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinomaGuilhem Bousquet, Morad El Bouchtaoui, Christophe Leboeuf, et al.
Experimental Hematology & Oncology|April 19, 2025
Anti-angiogenic tyrosine kinase inhibitors and the pathophysiology of their toxic effects: revisiting the treatment of anemia in metastatic cancersTai Van Nguyen, Eurydice Angeli, Diaddin Hamdan, et al.
Nano Letters|August 29, 2025
Photodynamic Therapy Using Pulsed-Laser Irradiation of Gold Nanoparticles for the Treatment of Cancers with High Basal Oxidative StressLéa Tourneur, Syrine Gueffrache, Khanh-van Do, et al.
Experimental Hematology & Oncology|April 15, 2024
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastasesEurydice Angeli, Justine Paris, Olivier Le Tilly, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 30, 2026
Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experienceJelena Filipovic, Emma Anjorand, Laetitia Marisa, et al.
Clinical and Translational Medicine|March 22, 2024
PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancersJustine Paris, Claire Wilhelm, Celeste Lebbé, et al.
Pageof 2